These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3072448)

  • 1. Laboratory evaluation of the TDx assay for detection of cannabinoids in urine from prison inmates.
    Karlsson L; Ström M
    J Anal Toxicol; 1988; 12(6):319-21. PubMed ID: 3072448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of fluorescence polarization immunoassay, enzyme immunoassay, and thin-layer chromatography for urine cannabinoid screening. Effects of analyte adsorption and vigorous mixing of specimen on detectability.
    Dextraze P; Griffiths WC; Camara P; Audette L; Rosner M
    Ann Clin Lab Sci; 1989; 19(2):133-8. PubMed ID: 2546480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of various immunologic methods with a GC-MS analysis in cannabinoid detection in urine].
    Käferstein H; Sticht G; Staak M
    Beitr Gerichtl Med; 1989; 47():115-22. PubMed ID: 2684146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations on radioimmunoassay, fluorescence polarization immunoassay, and enzyme immunoassay of cannabis metabolites with gas chromatography/mass spectrometry analysis of 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid in urine specimens.
    Weaver ML; Gan BK; Allen E; Baugh LD; Liao FY; Liu RH; Langner JG; Walia AS; Cook LF
    Forensic Sci Int; 1991; 49(1):43-56. PubMed ID: 1851715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of interference by nabilone in the EMIT d.a.u. cannabinoid assay, Abbott TDx cannabinoid assay, and a sensitive TLC assay for delta 9-THC-carboxylic acid.
    Fraser AD; Meatherall R
    J Anal Toxicol; 1989; 13(4):240. PubMed ID: 2550703
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of six cannabinoid metabolite assays.
    Frederick DL; Green J; Fowler MW
    J Anal Toxicol; 1985; 9(3):116-20. PubMed ID: 3892161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine cannabinoid analysis: an integrated multi-method approach.
    Black DL; Goldberger BA; Isenschmid DS; White SM; Caplan YH
    J Anal Toxicol; 1984; 8(5):224-7. PubMed ID: 6389979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-reactivity of selected compounds in the Abbott TDx cannabinoid assay.
    ElSohly MA; Jones AB; ElSohly HN
    J Anal Toxicol; 1990; 14(5):277-9. PubMed ID: 2175818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of a TLC method with EMIT and GC/MS for detection of cannabinoids in urine.
    Foltz RL; Sunshine I
    J Anal Toxicol; 1990; 14(6):375-8. PubMed ID: 2087098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of cannabinoids in urine: a cost-effective low risk immunoassay procedure.
    Moore FM; Simpson D
    Med Lab Sci; 1991 Jan; 48(1):76-9. PubMed ID: 1905775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Confirmation of EMIT cannabinoid assay results by bonded phase adsorption with thin layer chromatography.
    Willson NJ; Kogan MJ; Pierson DJ; Newman E
    J Toxicol Clin Toxicol; 1983 Jul; 20(5):465-73. PubMed ID: 6366244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of the Syva EMIT and Abbott TDx amphetamine immunoassays to the detection of 3,4-methylene-dioxymethamphetamine (MDMA) and 3,4-methylene-dioxyethamphetamine (MDEA) in urine.
    Kunsman GW; Manno JE; Cockerham KR; Manno BR
    J Anal Toxicol; 1990; 14(3):149-53. PubMed ID: 1973747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lowering the federally mandated cannabinoid immunoassay cutoff increases true-positive results.
    Huestis MA; Mitchell JM; Cone EJ
    Clin Chem; 1994 May; 40(5):729-33. PubMed ID: 8174244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interference by nonsteroidal anti-inflammatory drugs in EMIT and TDx assays for drugs of abuse.
    Joseph R; Dickerson S; Willis R; Frankenfield D; Cone EJ; Smith DR
    J Anal Toxicol; 1995; 19(1):13-7. PubMed ID: 7723297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Confirmation of Syva enzyme multiple immunoassay technique (EMIT) d.a.u. and Roche Abuscreen radioimmunoassay (RIA) (125I) urine cannabinoid immunoassays by gas chromatographic/mass spectrometric (GC/MS) and bonded-phase adsorption/thin-layer chromatographic (BPA-TLC) methods.
    Kogan MJ; Al Razi J; Pierson DJ; Willson NJ
    J Forensic Sci; 1986 Apr; 31(2):494-500. PubMed ID: 3011956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of two rapid, automated methods for determining aminoglycoside levels.
    Ngui-Yen JH; Doyle PW; Smith JA
    J Clin Microbiol; 1984 Nov; 20(5):962-5. PubMed ID: 6392328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary cannabinoid analysis: comparison of four immunoassays with gas chromatography-mass spectrometry.
    Altunkaya D; Clatworthy AJ; Smith RN; Start IJ
    Forensic Sci Int; 1991; 50(1):15-22. PubMed ID: 1937304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passive inhalation of marihuana smoke and urinary excretion of cannabinoids.
    Perez-Reyes M; Di Guiseppi S; Mason AP; Davis KH
    Clin Pharmacol Ther; 1983 Jul; 34(1):36-41. PubMed ID: 6305545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and confirmation of urinary cannabinoids.
    Sutheimer CA; Yarborough R; Hepler BR; Sunshine I
    J Anal Toxicol; 1985; 9(4):156-60. PubMed ID: 4033071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary excretion half-life of delta 1-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking.
    Johansson E; Halldin MM
    J Anal Toxicol; 1989; 13(4):218-23. PubMed ID: 2550702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.